全基因组关联研究识别MAPT位点影响人血浆tau水平
联合分析p=1.2×10^-12)。PARK2、IL2RA及9p21.3区域位点呈提示性关联。结论提示血浆tau浓度可能作为识别老年个体4重复tau蛋白病风险的中间表型。
要点
- MAPT基因rs242557位点A等位基因与血浆tau水平升高呈剂量依赖性关联。
- 该关联在全基因组显著性水平成立(p=4.85×10^-9),并在独立队列中验证。
- 血浆tau浓度可能作为4重复tau蛋白病风险的中间表型。
核心结论
- MAPT H1c单倍型(rs242557)与血浆tau水平升高显著相关,提示血浆tau浓度可能作为识别老年个体4重复tau蛋白病风险的中间表型。
研究设计与样本
- 显著关联在独立复制队列中验证,该队列由加州大学旧金山分校记忆与衰老中心招募的431名健康老人或轻度认知障碍个体组成。
主要发现
- MAPT基因rs242557位点A等位基因与较高血浆tau水平在全基因组显著性水平相关(p=4.85×10^-9,经验性家庭wise误差校正p=0.0024),呈剂量依赖性。
- 该关联在复制队列中亦观察到(p=1.0×10^-5;联合分析p=1.2×10^-12)。
- PARK2附近rs2187213(p=6.15×10^-6)、IL2RA附近rs7072793和rs7073236(p=7.89×10^-6)及9p21.3区域rs7047280(p=8.13×10^-6)被识别为与血浆tau水平相关的提示性位点。
临床怎么用
- 血浆tau浓度或可用于识别老年个体中4重复tau蛋白病(如进行性核上性麻痹和皮质基底节变性)的风险。
- MAPT rs242557位点可作为血浆tau水平相关的遗传标记,辅助风险分层。
局限性
- 研究样本限于非西班牙裔白人,结果外推至其他人群需谨慎。
- PARK2、IL2RA及9p21.3位点仅为提示性关联,未达到全基因组显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify genetic loci associated with plasma tau concentrations in healthy elders and individuals with Alzheimer disease. METHODS: Four hundred sixty-three non-Hispanic white individuals exceeding quality control criteria were included from the Alzheimer's Disease Neuroimaging Initiative (ADNI-1) cohort. Association of plasma tau with genetic polymorphisms was performed with a linear regression model. Significant associations were validated in an independent replication cohort consisting of 431 healthy elders or individuals with mild cognitive impairment recruited from the University of California, San Francisco Memory and Aging Center. RESULTS: The minor allele (A) of rs242557 in the microtubule-associated protein tau gene (MAPT) was associated with higher plasma tau levels at genome-wide significance (p = 4.85 × 10-9, empiric family-wise error corrected p = 0.0024) in a dose-dependent fashion. This association was also observed in the replication cohort (p = 1.0 × 10-5; joint analysis p = 1.2 × 10-12). Single nucleotide polymorphisms near PARK2 (rs2187213) (p = 6.15 × 10-6), IL2RA (rs7072793, rs7073236) (p = 7.89 × 10-6), and an intergenic locus on 9p21.3 (rs7047280) (p = 8.13 × 10-6) were identified as suggestive loci associated with plasma tau levels. CONCLUSIONS: MAPT H1c haplotype (rs242557) has previously been identified as a genetic risk factor for progressive supranuclear palsy and corticobasal degeneration. The current findings suggest that plasma tau concentration could be an endophenotype for identifying risk for 4-repeat tauopathies in older individuals.
引用
- Chen J, Yu JT, Wojta K, et al. Genome-wide association study identifies MAPT locus influencing human plasma tau levels. Neurology. 2017. PMID: 28100725. doi:10.1212/WNL.0000000000003615
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。